Skip to content
Screener

Total debt at other companies

Pfizer logo
PfizerPFE
$64.43B+4.9%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$350.49M+4.2%
AbbVie logo
AbbVieABBV
$62.36B+1.8%
Immunome logo
ImmunomeIMNM
$3.69M-22.6%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$114M+4.6%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$2.07M+36.3%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$2.3B+1,350%
Enterprise value$2.19B+1,537%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $871K.

The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001390478-26-000008

FAQ

What is SELLAS Life Sciences Group, Inc.'s total debt?
SELLAS Life Sciences Group, Inc. (SLS) reported total debt of $871K in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s total debt changed year-over-year?
SELLAS Life Sciences Group, Inc.'s total debt increased by 0.1% year-over-year, from $870K to $871K.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total debt?
Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s total debt has grown at a 0.2% compound annual growth rate (CAGR), from $991K to $1M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about SELLAS Life Sciences Group, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude